You can find us at the Department of Pharmacology in the 2nd floor of Biomedicum Helsinki 1. If you are interested in joining or collaborating with us, feel free to contact us at email@example.com.
MD, PhD, Group leader, Professor
Pekka is Senior Lecturer in pharmacology at the Medicum and is also medical advisor for the Finnish Center for Integrity in Sports (FINCIS) since 2018. Rauhala worked also as part-time medical advisor for Orion Pharma 2000–2018. He performed his postdoctoral studies in 1994–1997 at the National Institute of Mental Health NIH, where he worked with Prof. C.C. Chiueh on neurodegeneration in Parkinson’s disease. His research has concentrated on oxidative stress and neurodegeneration, neuroprotection, the dopaminergic system, opioid pharmacology and tolerance.
MD, PhD, Group leader, Professor
Eija is professor of pain medicine since 2004. She performed her postdoctoral studies at the University of Oxford with Sir Keith Sykes (1983–1984, pulmonary physiology & pharmacokinetics of opioids) and with Prof. H. J. McQuay, Oxford and A. H. Dickenson, UCL, London (spinal mechanisms of opioid analgesia and tolerance 1990–1991), and 1997 (evidence-based medicine with Prof. McQuay). In 1999 she worked at the Karolinska Institute with Prof. Martin Ingvar (placebo & opioid analgesia using PET).
Prof. Kalso has developed pain research in different fields: single and multi-centre clinical trials (acute, cancer and neuropathic pain) and evidence-based medicine, pharmacokinetics of opioids, basic pharmacology of opioids and α2-adrenergic agonists in different types of pain, imaging (PET, fMRI: opioid and placebo effects, neuropathic pain in HSV-patients, effects of chronic pain on the brain), and lately, genetics of pain and inter-individual variation in response to pain therapies, and the role of glial activation in opioid tolerance and neuropathic pain. She has published about 200 original articles and has 2 patents. She is the past president of the International Association for the Study of Pain and the current chair for the Scientific Programme Committee of the next Congress of the European Pain Federation, to be held in Dublin in 2021.
MD, PhD Postdoctoral Fellow
Tuomas received his PhD in 2014, at the Faculty of Medicine, University of Helsinki and has continued working on the group’s research projects. His doctoral thesis concentrated on pharmacological treatments for augmenting opioid analgesia and preventing tolerance. He has worked as a resident physician in Helsinki University Central Hospital. He is currently postdoctoral fellow at Institute of Biomedicine, Pharmacology, University of Helsinki and assistant professor in the laboratory of Prof. Nedergaard in Center for Translational Neuromedicine in Denmark.
PhD, Postdoctoral Fellow
Hanna received her PhD degree in 2012, at the Faculty of Medicine, University of Helsinki. Dr. Viisanen-Kuopila worked with Prof. A. Pertovaara in the Department of Physiology and studied role of pain modulatory pathways in chronic pain. She was a visiting scientist in the laboratory of Prof H.G. Schaible in the Friedrich-Schiller-University Jena, Germany during 2009-2010.
During her post-doctoral period in Department of Physiology, University of Helsinki (2012-2014) she studied the pathophysiology of peripheral diabetic neuropathy. She joined the group of Prof. E. Kalso and Dr. P. Rauhala in 2015.
Viljami received his PhD in 2017, at the Faculty of Medicine, University of Helsinki. His doctoral thesis concentrated on pharmacological treatments for augmenting opioid analgesia and preventing tolerance.